In our cohort, while tumors that have MiTF pathway activation without TFE3 rearrangement (i.e., granular cell tumor and melanoma) demonstrated TRIM63 RNA hybridization, they generally did so at a lower level than that of ASPS, with lower average H-scores (p < 0.05). The gene discussed is MITF; the disease is melanoma.